Since we have found that IL‐6 is associated with COVID‐19 severity, we suggest that targeting IL‐6 may ameliorate cytokine storm‐related symptoms in severe COVID‐19 cases (Emery et al, 2008; Norelli et al, 2018). The gene discussed is IL6; the disease is COVID-19.